The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Plaque Psoriasis Treatment-Global Market Insights and Sales Trends 2024
Synopsis
Plaque psoriasis is an inherited systemic inflammatory disease of immune dysfunction that causes plaques of elevated, scaling, inflamed skin that is often quite itchy.
The global Plaque Psoriasis Treatment market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Plaque Psoriasis Treatment in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Plaque Psoriasis Treatment market. Topical Therapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Phototherapy segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Plaque Psoriasis Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Plaque Psoriasis Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Plaque Psoriasis Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Plaque Psoriasis Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Plaque Psoriasis Treatment covered in this report include Allergan, Johnson and Johnson, Amgen, Abbvie, Eli Lilly, Dermira, Novartis, Galectin Therapeutics and Cellceutix, etc.
The global Plaque Psoriasis Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Allergan
Johnson and Johnson
Amgen
Abbvie
Eli Lilly
Dermira
Novartis
Galectin Therapeutics
Cellceutix
Biogen
Bayer
Global Plaque Psoriasis Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Plaque Psoriasis Treatment market, Segment by Type:
Topical Therapy
Phototherapy
Systemic Agents
Biologic Therapies
Global Plaque Psoriasis Treatment market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Plaque Psoriasis Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Plaque psoriasis is an inherited systemic inflammatory disease of immune dysfunction that causes plaques of elevated, scaling, inflamed skin that is often quite itchy.
The global Plaque Psoriasis Treatment market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Plaque Psoriasis Treatment in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Plaque Psoriasis Treatment market. Topical Therapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Phototherapy segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Plaque Psoriasis Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Plaque Psoriasis Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Plaque Psoriasis Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Plaque Psoriasis Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Plaque Psoriasis Treatment covered in this report include Allergan, Johnson and Johnson, Amgen, Abbvie, Eli Lilly, Dermira, Novartis, Galectin Therapeutics and Cellceutix, etc.
The global Plaque Psoriasis Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Allergan
Johnson and Johnson
Amgen
Abbvie
Eli Lilly
Dermira
Novartis
Galectin Therapeutics
Cellceutix
Biogen
Bayer
Global Plaque Psoriasis Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Plaque Psoriasis Treatment market, Segment by Type:
Topical Therapy
Phototherapy
Systemic Agents
Biologic Therapies
Global Plaque Psoriasis Treatment market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Plaque Psoriasis Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Plaque Psoriasis Treatment
1.1 Plaque Psoriasis Treatment Market Overview
1.1.1 Plaque Psoriasis Treatment Product Scope
1.1.2 Plaque Psoriasis Treatment Market Status and Outlook
1.2 Global Plaque Psoriasis Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Plaque Psoriasis Treatment Market Size by Region (2018-2029)
1.4 Global Plaque Psoriasis Treatment Historic Market Size by Region (2018-2023)
1.5 Global Plaque Psoriasis Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Plaque Psoriasis Treatment Market Size (2018-2029)
1.6.1 North America Plaque Psoriasis Treatment Market Size (2018-2029)
1.6.2 Europe Plaque Psoriasis Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Plaque Psoriasis Treatment Market Size (2018-2029)
1.6.4 Latin America Plaque Psoriasis Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Plaque Psoriasis Treatment Market Size (2018-2029)
2 Plaque Psoriasis Treatment Market by Type
2.1 Introduction
2.1.1 Topical Therapy
2.1.2 Phototherapy
2.1.3 Systemic Agents
2.1.4 Biologic Therapies
2.2 Global Plaque Psoriasis Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Plaque Psoriasis Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Plaque Psoriasis Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Plaque Psoriasis Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Plaque Psoriasis Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Plaque Psoriasis Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Plaque Psoriasis Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Plaque Psoriasis Treatment Revenue Breakdown by Type (2018-2029)
3 Plaque Psoriasis Treatment Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Others
3.2 Global Plaque Psoriasis Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Plaque Psoriasis Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Plaque Psoriasis Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Plaque Psoriasis Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Plaque Psoriasis Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Plaque Psoriasis Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Plaque Psoriasis Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Plaque Psoriasis Treatment Revenue Breakdown by Application (2018-2029)
4 Plaque Psoriasis Treatment Competition Analysis by Players
4.1 Global Plaque Psoriasis Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Plaque Psoriasis Treatment as of 2022)
4.3 Date of Key Players Enter into Plaque Psoriasis Treatment Market
4.4 Global Top Players Plaque Psoriasis Treatment Headquarters and Area Served
4.5 Key Players Plaque Psoriasis Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Plaque Psoriasis Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Allergan
5.1.1 Allergan Profile
5.1.2 Allergan Main Business
5.1.3 Allergan Plaque Psoriasis Treatment Products, Services and Solutions
5.1.4 Allergan Plaque Psoriasis Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 Allergan Recent Developments
5.2 Johnson and Johnson
5.2.1 Johnson and Johnson Profile
5.2.2 Johnson and Johnson Main Business
5.2.3 Johnson and Johnson Plaque Psoriasis Treatment Products, Services and Solutions
5.2.4 Johnson and Johnson Plaque Psoriasis Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 Johnson and Johnson Recent Developments
5.3 Amgen
5.3.1 Amgen Profile
5.3.2 Amgen Main Business
5.3.3 Amgen Plaque Psoriasis Treatment Products, Services and Solutions
5.3.4 Amgen Plaque Psoriasis Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 Abbvie Recent Developments
5.4 Abbvie
5.4.1 Abbvie Profile
5.4.2 Abbvie Main Business
5.4.3 Abbvie Plaque Psoriasis Treatment Products, Services and Solutions
5.4.4 Abbvie Plaque Psoriasis Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 Abbvie Recent Developments
5.5 Eli Lilly
5.5.1 Eli Lilly Profile
5.5.2 Eli Lilly Main Business
5.5.3 Eli Lilly Plaque Psoriasis Treatment Products, Services and Solutions
5.5.4 Eli Lilly Plaque Psoriasis Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 Eli Lilly Recent Developments
5.6 Dermira
5.6.1 Dermira Profile
5.6.2 Dermira Main Business
5.6.3 Dermira Plaque Psoriasis Treatment Products, Services and Solutions
5.6.4 Dermira Plaque Psoriasis Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 Dermira Recent Developments
5.7 Novartis
5.7.1 Novartis Profile
5.7.2 Novartis Main Business
5.7.3 Novartis Plaque Psoriasis Treatment Products, Services and Solutions
5.7.4 Novartis Plaque Psoriasis Treatment Revenue (US$ Million) & (2018-2023)
5.7.5 Novartis Recent Developments
5.8 Galectin Therapeutics
5.8.1 Galectin Therapeutics Profile
5.8.2 Galectin Therapeutics Main Business
5.8.3 Galectin Therapeutics Plaque Psoriasis Treatment Products, Services and Solutions
5.8.4 Galectin Therapeutics Plaque Psoriasis Treatment Revenue (US$ Million) & (2018-2023)
5.8.5 Galectin Therapeutics Recent Developments
5.9 Cellceutix
5.9.1 Cellceutix Profile
5.9.2 Cellceutix Main Business
5.9.3 Cellceutix Plaque Psoriasis Treatment Products, Services and Solutions
5.9.4 Cellceutix Plaque Psoriasis Treatment Revenue (US$ Million) & (2018-2023)
5.9.5 Cellceutix Recent Developments
5.10 Biogen
5.10.1 Biogen Profile
5.10.2 Biogen Main Business
5.10.3 Biogen Plaque Psoriasis Treatment Products, Services and Solutions
5.10.4 Biogen Plaque Psoriasis Treatment Revenue (US$ Million) & (2018-2023)
5.10.5 Biogen Recent Developments
5.11 Bayer
5.11.1 Bayer Profile
5.11.2 Bayer Main Business
5.11.3 Bayer Plaque Psoriasis Treatment Products, Services and Solutions
5.11.4 Bayer Plaque Psoriasis Treatment Revenue (US$ Million) & (2018-2023)
5.11.5 Bayer Recent Developments
6 North America
6.1 North America Plaque Psoriasis Treatment Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Plaque Psoriasis Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Plaque Psoriasis Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Plaque Psoriasis Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Plaque Psoriasis Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Plaque Psoriasis Treatment Market Dynamics
11.1 Plaque Psoriasis Treatment Industry Trends
11.2 Plaque Psoriasis Treatment Market Drivers
11.3 Plaque Psoriasis Treatment Market Challenges
11.4 Plaque Psoriasis Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
